Toggle light / dark theme

· 24 mins ·

Safety was the reason the WHO stopped clinical trials of a drug that is not even an amphetamine. This happened before the racial divide, distraction, and mass confusion.

So let US think with a clear head. If Hydroxychloroquine is unsafe because of heart concerns, why give children amphetamines for ADHD, when marijuana and other natural measures offer many more safer alternatives? I know of them, why don’t the WHO and FDA, who know more than I do know as well? I can start a w… See More.


First-line stimulant class medications, such as methylphenidate and amphetamine formulations are FDA approved for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and narcolepsy. It is estimated that 4.4% of US adults experience some symptoms and disabilities of ADHD. However adults receive 32% of all issued stimulant prescriptions.1 Off-label treatment for conditions including weight management, fatigue related to depression, stroke, traumatic brain injury, or hyper-somnolence due to Obstructive Sleep Apnea (OSA) may account for the high prevalence of stimulant use in adults. Such conditions are frequently associated with history or risk of cardiovascular disease. Of note, OSA and other forms of sleep-disordered breathing have unfavorable effects on cardiovascular physiology, predisposing affected individuals to cardiovascular disease and cardiac arrhythmias.2,3

Ira Pastor, ideaXme life sciences ambassador, interviews Dr. Eric Van Gieson, Program Manager in the Biological Technologies Office (BTO) at DARPA. https://www.darpa.mil/staff/dr-eric-van-gieson

Ira Pastor Comments

On several recent ideaXme episodes, we have spent time on different topics pertaining to human health, disease, degeneration and aging, focused on a variety of therapeutic and preventative interventions being developed in the private sector of the economy, both here in the U.S. and more broadly globally.

We’ve also had representatives from various independent agencies of the United States Federal Government, the UK government (UKRI), and other foreign governmental agencies, join us to discuss many of the exciting public sector discoveries and development occurring, that possess massive trickle down benefits to the general public.

Nearly 4 in 10 American adults reported engaging in dangerous cleaning practices to prevent COVID-19, such as washing food with bleach, using household disinfecting products on their skin or intentionally inhaling vapors from cleaning products, according to a recent survey.

A report from the Centers for Disease Control and Prevention (CDC) follows an earlier study describing an increase in calls to poison control centers regarding exposure to household cleaners, during the COVID-19 pandemic.

The first patients have been dosed in a study of LY-CoV555, the lead antibody from Lilly’s collaboration with AbCellera. See our blog at: https://www.futuretimeline.net/blog/2020/06/4-covid-19-antibodies.htm

Follow us on Twitter: https://twitter.com/future_timeline
Follow us on Instagram: https://www.instagram.com/ftimeline/
Follow us on Facebook: https://www.facebook.com/futuretimeline.net/
Follow us on Reddit: https://www.reddit.com/r/futuretimeline/

Technion Professor Ido Kaminer and his team have made a dramatic breakthrough in the field of quantum science: a quantum microscope that records the flow of light, enabling the direct observation of light trapped inside a photonic crystal.

Their research, “Coherent Interaction Between Free Electrons and a Photonic Cavity,” was published in Nature. All the experiments were performed using a unique ultrafast transmission electron microscope at the Technion-Israel Institute of Technology. The microscope is the latest and most versatile of a handful that exist in the scientific world.

“We have developed an electron microscope that produces, what is in many respects, the best near- field optical microscopy in the world. Using our microscope, we can change the color and angle of light that illuminates any sample of nano materials and map their interactions with electrons, as we demonstrated with photonic crystals,” explained Prof. Kaminer. “This is the first time we can actually see the dynamics of light while it is trapped in nano materials, rather than relying on ,” added Dr. Kangpeng Wang, a postdoc in the group and first author on the paper.

A team including researchers from the Department of Chemistry at the University of Tokyo has successfully captured video of single molecules in motion at 1,600 frames per second. This is 100 times faster than previous experiments of this nature. They accomplished this by combining a powerful electron microscope with a highly sensitive camera and advanced image processing. This method could aid many areas of nanoscale research.

When it comes to film and video, the number of images captured or displayed every second is known as the frames per second or fps. If video is captured at high fps but displayed at lower fps, the effect is a smooth slowing down of motion which allows you to perceive otherwise inaccessible details. For reference, films shown at cinemas have usually been displayed at 24 frames per second for well over 100 years. In the last decade or so, special microscopes and cameras have allowed researchers to capture atomic-scale events at about 16 fps. But a new technique has increased this to a staggering 1,600 fps.

Paleontologists at St Petersburg University created the most detailed virtual 3D-model of the endocranial cast and blood vessels of the head of an ankylosaurian.

Paleontologists from St Petersburg University have been the first to study in detail the structure of the brain and blood vessels in the skull of the ankylosaur Bissektipelta archibaldi. It was a herbivorous dinosaur somewhat similar in appearance to a modern armadillo. The first three-dimensional computer reconstruction of a dinosaur endocast made in Russia — a digital cast of its braincase — was of help to the scientists. It made it possible to find out that ankylosaurs, and Bissektipelta in particular, were capable of cooling their brains, had an extremely developed sense of smell, and heard low-frequency sounds. However, their brain was one and a half times smaller than that of modern animals of the same size.

Ankylosaurs appeared on Earth in the middle of the Jurassic — about 160 million years ago — and existed until the end of the dinosaur era, which ended 65 million years ago. These herbivorous animals were somewhat reminiscent of modern turtles or armadillos, were covered with thick armor, and sometimes even had a bony club on the tail. The researchers became interested in the uniquely-preserved remains of ankylosaurs from Uzbekistan. Although these fossils have been known for 20 years, only now have the scientists had a unique opportunity to study the specimens from the inside using cutting-edge methods.